{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:03:03Z","timestamp":1782907383409,"version":"3.54.5"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Surveillance of antimicrobial consumption (AMC) is important to address inappropriate use. AMC data for countries in the European Union (EU) and European Economic Area (EEA) and Eastern European and Central Asian countries were compared to provide future guidance.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Analyses of 2014\u20132018 data from 30 EU\/EEA countries of the European Surveillance of Antibiotic Consumption network (ESAC-Net) and 15 countries of the WHO Regional Office for Europe (WHO Europe) AMC Network were conducted using the Anatomical Therapeutic Chemical (ATC) classification and Defined Daily Dose (DDD) methodology. Total consumption (DDD per 1000 inhabitants per day) of antibacterials for systemic use (ATC group J01), relative use (percentages), trends over time, alignment with the WHO Access, Watch, Reserve (AWaRe) classification, concordance with the WHO global indicator (60% of total consumption should be Access agents), and composition of the drug utilization 75% (DU75%) were calculated.<\/jats:p><jats:p><jats:bold>Findings:<\/jats:bold> In 2018, total consumption of antibacterials for systemic use (ATC J01) ranged from 8.9 to 34.1 DDD per 1000 inhabitants per day (population-weighted mean for ESAC-Net 20.0, WHO Europe AMC Network 19.6, ESAC-Net Study Group, and WHO Europe AMC Network Study Group). ESAC-Net countries consumed more penicillins (J01C; 8.7 versus 6.3 DDD per 1000 inhabitants per day), more tetracyclines (J01A; 2.2 versus 1.2), less cephalosporins (J01D; 2.3 versus 3.8) and less quinolones (J01M; 1.7 versus 3.4) than WHO Europe AMC Network countries. Between 2014 and 2018, there were statistically significant reductions in total consumption in eight ESAC-Net countries. In 2018, the relative population-weighted mean consumption of Access agents was 57.9% for ESAC-Net and 47.4% for the WHO Europe AMC Network. For each year during 2014\u20132018, 14 ESAC-Net and one WHO Europe AMC Network countries met the WHO global monitoring target of 60% of total consumption being Access agents. DU75% analyses showed differences in the choices of agents in the two networks.<\/jats:p><jats:p><jats:bold>Interpretation:<\/jats:bold> Although total consumption of antibacterials for systemic use was similar in the two networks, the composition of agents varied substantially. The greater consumption of Watch group agents in WHO Europe AMC Network countries suggests opportunities for improved prescribing. Significant decreases in consumption in several ESAC-Net countries illustrate the value of sustained actions to address antimicrobial resistance.<\/jats:p>","DOI":"10.3389\/fphar.2021.639207","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T15:34:02Z","timestamp":1641396842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014\u20132018: Findings and Implications from ESAC-Net and WHO Europe"],"prefix":"10.3389","volume":"12","author":[{"given":"Jane","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Vlahovi\u0107-Pal\u010devski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotoji","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liselotte Diaz","family":"H\u00f6gberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Godman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique L.","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Weist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESAC-Net Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"WHO Europe AMC Network Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4045\/tidsskr.16.0621","article-title":"Antibiotikabruk og infeksjoner i sykehjem","volume":"137","author":"Alberg","year":"2017","journal-title":"Tidsskriftet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s1473-3099(19)30004-0","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/qshc.2006.021121","article-title":"European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe","volume":"16","author":"Coenen","year":"2007","journal-title":"Qual. Saf. Health Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/inf.0000000000001324","article-title":"Using prescription patterns in primary care to derive new quality indicators for childhood community antibiotic prescribing","volume":"35","author":"de Bie","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B5","article-title":"Antimicrobial consumption","volume-title":"ECDC. Annual epidemiological report 2018","year":""},{"key":"B6","article-title":"European surveillance of antimicrobial consumption network (ESAC-Net)","volume-title":"European Centre for disease prevention and Control","year":"2020"},{"key":"B7","volume-title":"Surveillance of antimicrobial resistance in Europe 2018","year":""},{"key":"B8","unstructured":"ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals"},{"key":"B9","unstructured":"ECDC\/EFSA\/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals \u2013 joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA) Report"},{"key":"B10","unstructured":"A European one health action plan against antimicrobial resistance (AMR)2017"},{"key":"B12","volume-title":"Eurostat [internet]","year":""},{"key":"B11","unstructured":"European neighbourhood policy and enlargement negotiations"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e012244","DOI":"10.1136\/bmjopen-2016-012244","article-title":"Why do general practitioners prescribe antibiotics for upper respiratory tract infections to meet patient expectations: a mixed methods study","volume":"6","author":"Fletcher-Lartey","year":"2016","journal-title":"BMJ Open"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41579-018-0125-x","article-title":"The cost of antimicrobial resistance","volume":"17","author":"Hofer","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1473-3099(18)30547-4","article-title":"Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries","volume":"19","author":"Hsia","year":"","journal-title":"Lancet Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e861","DOI":"10.1016\/S2214-109X(19)30071-3","article-title":"Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries","volume":"7","author":"Hsia","year":"","journal-title":"Lancet Glob. Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1473-3099(20)30332-7","article-title":"Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data","volume":"21","author":"Klein","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/s1473-3099(20)30003-7","article-title":"The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later","volume":"20","author":"Laxminarayan","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9788","DOI":"10.1038\/s41598-019-50846-1","article-title":"Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse","volume":"9","author":"Malik","year":"2019","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/antibiotics8040189","article-title":"Analysis of the antimicrobial market in Pakistan: is it really necessary such a vast offering of \u201cWatch\u201d antimicrobials?","volume":"8","author":"Malik","year":"2019","journal-title":"Antibiotics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1016\/s2214-109x(17)30365-0","article-title":"Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship","volume":"5","author":"McGettigan","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","article-title":"Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review","volume":"8","author":"Nathwani","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"B24","unstructured":"Tackling drug-resistance infections globally: final report and recommendations of the review on antimicrobial resistance\n            O\u2019NeillJ.\n          2016"},{"key":"B25","unstructured":"Canadian antimicrobial resistance surveillance system report2020"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s10096-019-03572-5","article-title":"The use of a poster to reduce expectations to receive antibiotics for a common cold","volume":"38","author":"Ritchie","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3389\/fphar.2018.01156","article-title":"Antimicrobial medicines consumption in Eastern Europe and Central Asia \u2013 an updated cross-national study and assessment of quantitative metrics for policy action","volume":"9","author":"Robertson","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.healthpol.2016.12.010","article-title":"Corruption and use of antibiotics in regions of Europe","volume":"121","author":"R\u00f6nnerstrand","year":"2017","journal-title":"Health Policy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S1473-3099(12)70017-8","article-title":"Antibiotics obtained without a prescription in Europe","volume":"12","author":"Safrany","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1093\/jac\/dky345","article-title":"Antibiotic consumption in Germany: first data of a newly implemented web-based tool for local and national surveillance","volume":"73","author":"Schweickert","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S1473-3099(19)30532-8","article-title":"Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool","volume":"19","author":"Sharland","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1037\/hea0000456","article-title":"Expectations for antibiotics increase their prescribing: causal evidence about localized impact","volume":"36","author":"Sirota","year":"2017","journal-title":"Health Psychol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"vi50","DOI":"10.1093\/jac\/dky118","article-title":"Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure","volume":"73","author":"Stanic Benic","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233345","article-title":"Communication training and the prescribing pattern of antibiotic prescription in primary health care","volume":"15","author":"Strumann","year":"2020","journal-title":"PloS one"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1003139","DOI":"10.1371\/journal.pmed.1003139","article-title":"Antibiotic prescription practices in primary care in low- and middle-income countries: a systematic review and meta-analysis","volume":"17","author":"Sulis","year":"2020","journal-title":"Plos Med."},{"key":"B36","unstructured":"DataBank: population estimates and projections2020"},{"key":"B37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s1473-3099(14)70071-4","article-title":"On behalf of the WHO\/Europe-ESAC Project GroupAntibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe","volume":"14","author":"Versporten","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B38","volume-title":"Anatomical Therapeutic Chemical (ATC) classification system: guidelines for ATC classification and DDD assignment 2020","year":"2020"},{"key":"B39","volume-title":"DDD: definition and general considerations","year":"2018"},{"key":"B40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13756-018-0428-8","article-title":"Antibiotic consumption and antimicrobial resistance in Poland; findings and implications","volume":"7","author":"Wojkowska-Mach","year":"2018","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"B41","unstructured":"Adopt AWaRe: handle antibiotics with care2020"},{"key":"B42","unstructured":"AWaRe classification database2019"},{"key":"B49","volume-title":"WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation","year":"2018"},{"key":"B43","unstructured":"Global action plan on antimicrobial resistance2015"},{"key":"B44","unstructured":"Antimicrobials"},{"key":"B48","unstructured":"WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network. AMC data 2011\u20132017"},{"key":"B47","unstructured":"European programme of work, 2020-2025 \u2013 \u2018united action for better health in Europe\u2019"},{"key":"B45","volume-title":"Central Asian and European Surveillance of Antimicrobial Resistance","year":"2018"},{"key":"B46","unstructured":"EUR\/RC61\/14 European strategic action plan on antibiotic resistance2011"},{"key":"B50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/157488411794941322","article-title":"Drug utilization 75% (DU75%) in 17 European hospitals (2000-2005): results from the ESAC-2 hospital care sub project","volume":"6","author":"Zarb","year":"2011","journal-title":"Curr. Clin. Pharmacol."}],"updated-by":[{"DOI":"10.3389\/fphar.2021.765748","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.639207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T15:34:19Z","timestamp":1641396859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.639207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":50,"alternative-id":["10.3389\/fphar.2021.639207"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.639207","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphar.2021.765748","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"article-number":"639207"}}